Effect of forskolin on bradykinin-induced calcium mobilization in cultured canine tracheal smooth muscle cells.
S F Luo, C T Chiu, H L Tsao, L W Fan, C T Tsai, S L Pan, C M Yang
Index: Cell. Signal. 9 , 159-167, (1997)
Full Text: HTML
Abstract
The effects of increases in intracellular adenosine 3':5'-cyclic monophosphate (cyclic AMP) on bradykinin (BK)-induced generation of inositol phosphates (IPs) and Ca2+ mobilization were investigated in canine cultured tracheal smooth muscle cells (TSMCs). Pretreatment of TSMCs with either forskolin or dibutyryl cyclic AMP attenuated BK-stimulated responses. The inhibitory effects of these agents produced both a depression of the maximal response and a shift to the right of the concentration-response curves of BK. The water-soluble forskolin analogue L-858051, 7-deacetyl-7 beta-(r-N-methylpiperazino)-butyryl forskolin, significantly attenuated BK-stimulated IPs accumulation, while 1,9-dideoxy forskolin, an inactive forskolin, had little effect on IPs response. Moreover, SQ-22536, 9-(tetrahydro-2-furanyl)-9-H-purin-6-amine, an inhibitor of adenylate cyclase, and both H-89, N-(2-aminoethyl)-5-isoquinolinesulfonamide, and HA-1004, N-(2-guanidinoethyl)-5-isoquinolinesulfonamide, inhibitors of cyclic AMP-dependent protein kinase (PKA), reversed the ability of forskolin to attenuate BK-stimulated IPs accumulation. The KD and Bmax, values of the BK receptor for [3H]BK binding were not significantly changed by forskolin treatment for 30 min and 4 h. The AlF4(-)-induced IPs accumulation was attenuated by forskolin, indicating that G protein(s) are directly activated by AlF4- and uncoupled to phospholipase C by forskolin treatment. These results suggest that activation of cyclic AMP/PKA might inhibit the BK-stimulated PI breakdown and consequently reduce the [Ca2+]i increases or inhibit independently both responses, which is distal to the BK receptor in canine cultured TSMCs.
Related Compounds
Related Articles:
1997-12-01
[Cell Growth Differ. 8 , 1317-1328, (1997)]
1997-02-07
[J. Biol. Chem. 272 , 3238-3245, (1997)]
1998-06-01
[J. Neurosci. Res. 52 , 530-537, (1998)]
1991-01-01
[Neuroscience 44 , 361-370, (1991)]
1994-05-01
[J. Cardiovasc. Pharmacol. 23 , 806-813, (1994)]